show help

Oberg B

Author page

This page provides a summary of the entries in Polbase associated with this author.

The publication history graph presents the number of publications in Polbase by this author over time.

The polymerase chart indicates which polymerases this author has published on.

Polbase automatically discovers many polymerase papers as they are published. Some relevant papers are not included because the algorithm is designed to reduce background. Please contribute to polbase by adding your missing DNA polymerase papers.

Help icons:

The show help symbol in the upper-right corner of the page links to this help text. The question mark icon is used everywhere to indicate that help is available.

Missing references?


Title Authors Year Journal
The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT. Oberg B 2004 Journal of virology
Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analogues. Oberg B 1999 J Med Chem
Inhibition of human immunodeficiency virus type 1 wild-type and mutant reverse transcriptases by the phenyl ethyl thiazolyl thiourea derivatives trovirdine and MSC-127. Oberg B 1995 Antiviral research
Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors. Oberg B 1993 Proceedings of the National Academy of Sciences of the United States of America
HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase. Oberg B 1993 Virology
Inhibition of human hepatitis B virus DNA polymerase and duck hepatitis B virus DNA polymerase by triphosphates of thymidine analogs and pharmacokinetic properties of the corresponding nucleosides. Oberg B 1988 J Med Virol
Inhibition of hepatitis B virus DNA polymerase by 3'-azido-3'-deoxythymidine triphosphate but not by its threo analog. Oberg B 1987 J Med Virol
Inhibition of HTLV-III/LAV replication by foscarnet. Oberg B 1985 Biochem Pharmacol
Antiviral effects of phosphonoformate (PFA, foscarnet sodium). Oberg B 1982 Pharmacol Ther
Pyrophosphate analogues as inhibitors of DNA polymerases of cytomegalovirus, herpes simplex virus and cellular origin. Oberg B 1982 Biochimica et biophysica acta
Inhibition of hepatitis B Dane particle DNA polymerase activity by pyrophosphate analogs. Oberg B 1980 Acta Pathol Microbiol Scand B
Pyrophosphate analogues as inhibitors of herpes simplex virus type 1 DNA polymerase. Oberg B 1980 Biochimica et biophysica acta
Trisodium phosphonoformate inhibits hepatitis B Dane particle DNA polymerase. Oberg B 1979 Acta Pathol Microbiol Scand B
Phosphonoformate inhibits reverse transcriptase. Oberg B 1979 The Journal of general virology
Trisodium phosphonoformate, a new antiviral compound. Oberg B 1978 Science

Using Polbase tables:


Tables may be sorted by clicking on any of the column titles. A second click reverses the sort order. <Ctrl> + click on the column titles to sort by more than one column (e.g. family then name).


It is also possible to filter the table by typing into the search box above the table. This will instantly hide lines from the table that do not contain your search text.